Literature DB >> 12367689

LC method for the analysis of cefetamet pivoxil hydrochloride in drug substance and powder for oral suspension.

Lisoni M Morsch1, Celso F Bittencourt, Marinês J e Souza, Julie Milano.   

Abstract

A high-performance liquid chromatography isocratic procedure was developed for the assay of cefetamet pivoxil hydrochloride in drug substance and powder for oral suspension. The method validation yielded good results and included the range, linearity, precision intra- inter-day, accuracy, specificity, LOD and LOQ values. The chromatographic system consisted of a C(18) absorbosphere column (150 x 4.6 mm i.d., 5 microm particle size), a mobile phase composed of water-acetonitrile-methanol-phosphate buffer, pH 3.5 (50:35:10:5, v/v), flow rate of 1.5 ml min(-1) and UV detection at 254 nm. The relative standard deviation varied between 0.03 and 1.76%, and accuracy of 100.09% was found. Calibration curve was linear from 30.0-80.0 microg ml(-1); its correlation coefficient was 0.99989. Copyright 2002 Elsevier Science B.V.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12367689     DOI: 10.1016/s0731-7085(02)00343-6

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  3 in total

1.  Pharmacokinetics and pharmacodynamics of oral and intravenous cefetamet in dog.

Authors:  Wei Wang; Xiao-Mao Zhu; Chun-Mei Wang; Si Gou; Zhong-Hua Chen; Yuan Zhao
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2014-07-13       Impact factor: 2.441

2.  Spectrophotometric Determination of Cefetamet Pivoxil Hydrochloride and Pitavastatin Calcium in Tablet Dosage form.

Authors:  N H Vadia; Vandana Patel; H N Bhalara
Journal:  Indian J Pharm Sci       Date:  2008-09       Impact factor: 0.975

3.  Formulation development and rheological studies of palatable cefetamet pivoxil hydrochloride dry powder suspension.

Authors:  Sb Sateesha; Aj Rajamma; Hs Shekar; G Divakar
Journal:  Daru       Date:  2011       Impact factor: 3.117

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.